The anti-secretory and anti-ulcer activities of esomeprazole in comparison with omeprazole in the stomach of rats and rabbits

Molecular and Cellular Biochemistry

Volumn 309, Issue 1-2, 2008, Pages 167-175

  Bastaki, Salim M A ^a   Chandranath, Irwin S ^a   Singh, Jaipaul ^b  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

Author keywords

Anti secretory; Anti ulcer; Esomeprazole; Omeprazole; Prostaglandin E2; Rabbit; Rat

Indexed keywords

ALCOHOL; BUCLADESINE; DIMAPRIT; ESOMEPRAZOLE; HISTAMINE; INDOMETACIN; OMEPRAZOLE; PROSTAGLANDIN E2; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG RESPONSE; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PROTEIN BINDING; RABBIT; RAT; STOMACH ACID SECRETION; STOMACH GLAND; STOMACH HEMORRHAGE; TISSUE LEVEL;

AMINOPYRINE; ANIMALS; ANTI-ULCER AGENTS; BUCLADESINE; CARBON ISOTOPES; DIMAPRIT; DINOPROSTONE; FEMALE; GASTRIC ACID; GASTRIC MUCOSA; HISTAMINE; INDOMETHACIN; INHIBITORY CONCENTRATION 50; MALE; OMEPRAZOLE; RABBITS; RATS; RATS, WISTAR; STOMACH;

ORYCTOLAGUS CUNICULUS; RATTUS;

EID: 38649085661     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-007-9657-5     Document Type: Article

References (46)

1. Li X, Andersson TB, Ahlstrom M, Weidolf L (2004) Comparison of inhibitory effects of the proton pump inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole and rabeprazole on human cytochrome P450 activities. Drug Metab Dispos 32:821-827
2. Larsson H, Carlsson E, Junggen U, Olbe L, Sjostrand SE, Skanberg I, Sundell G (1983) Inhibition of gastric secretion by omeprazole in the dog and rat. Gastroenterology 85:900-907
3. Satoh H, Inatomi N, Nagaya H, Inada I, Nohara A, Nakamura H (1989) Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats. J Pharmacol Exp Ther 248:806-815
4. +-ATPase activity in canine gastric microsomes and acid formation in isolated canine parietal cells. Biochem Pharmacol 42:1875-1878
5. Sachs G, Kaunitz J, Mendlein J, Wallmark B (1989) Biochemistry of gastric acid secretion. In: Forte JG (Ed) Handbook of physiology, section 6; The Gastrointestinal system, Vol. 3: Salivary, gastric and hepatobiliary secretion. American Physiological Society, Bethesda, pp 229-254
6. Miner PB, Katz PO, Chen Y (2003) Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: A five-way crossover study. Am J Gastroenterol 98:2616-2620
7. Goldstein JL, Johanson JF, Suchower LJ, Brown KA (2005) Healing of gastric ulcers with esomeprazole versus ranitidine in patients who continued to receive NSAID therapy: A randomized trial. Am J Gastroenterol 100:2650-2657
8. Robinson M (2001) New generation proton pump inhibitors: Overcoming the limitations of early-generation agents. Eur J Gastroenterol Hepatol 13 (suppl 1):S43-47
9. Johnson D (2003) Review of esomeprazole in the treatment of acid disorders. Expert Opin on Pharmacother 4:253-264
10. Li ZS, Zhan XB, Xu GM, Chen NN, Liao Z (2007) Effect of esomeprazole and rabeprazole on intragastric pH in health Chinese: An open, randomized crossover trial. J Gastroenterol Hepatol 22 (6):815-820
11. Johnson DS, Stacy T, Ryan M, Wootton T, Willis J, Hornbuckle K, Brooks W, Doviak M (2005) A comparison of esomeprazole and lansoprazole for control of intragastric pH in patients with symptoms of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 22:129-134
12. + -ATPase. Nature (Lond) 290:159-165
13. Kobayashi T, Ohta Y, Inui K, Yoshino J, Nakazawa S (2002) Protective effect of omeprazole against acute gastric mucosal lesions induced by compound 48/80, a mast cell degranulator, in rats. Pharmacol Res 46:75-84
14. Thjodleifsson B (2002) Treatment of acid-related diseases in the elderly with emphasis on the use of proton pump inhibitors. Drugs Aging 19 (12):911-927
15. Berglindh T, Obrink KJ (1976) A method for preparing isolated glands from the rabbit gastric mucosa. Acta Physiol Scand 96 (2):150-159
16. Garner A, Chandranath I, Hasan MY, Bastaki SMA (1993) Relative merits of two novel antisecretory drugs acting via H+/K+ -ATPase inhibition and CCK receptors. Meeting Br Soc Gastroenterol 65:S17 (an abstract)
17. Berglindh T (1990) Gastric glands and cells: Preparation and in vitro methods. Methods Enzymol 192:93-107
18. Chandranath SI, Bastaki SMA, Singh J (2002) Comparative study on the activity of lansoprazole, omeprazole and PD-136450 on acidified ethanol- and indomethacin-induced gastric lesions in the rat. Clin Exp Pharmacol Physiol 29:173-180
19. Bastaki SMA, Chandranath SI, Singh J (2002) Comparison of the antisecretory and antiulcer activity of epidermal growth factor, urogastrone and transforming growth factor alpha and its derivative in rodents in vivo. Mol Cell Biochem 236:83-94
20. 2 in the ulcer preventing ability of leptin. Gut 53 (Suppl. 3):A77 (an abstract)
21. Mercer DW, Cross JM, Barreto JC, Strobel NH, Russel DH, Miller TA (1995) Cholecystokinin is a potent protective agent against alcohol-induced gastric injury in the rat. Dig Dis Sci 40:651-660
22. Nishida A, Takinami Y, Yuki H, Kobayashi A, Akuzawa S, Kamata T, Ito H, Yamano M, Nagakura Y, Miyata K (1994) YM022®-1-[2,3-dihydro-1- (2′-methylphenacyl)-2-oxo-5-phenyl-1H-1,4benzodiazepin-3-yl]- (methylphenyl)urea), a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats. J Pharmacol Exp Ther 270:1256-1261
23. Satoh H, Guth PH, Grossmann MI (1982) Role of food in gastrointestinal ulceration produced by indomethacin in the rat. Gastroenterology 32 (5):945-949
24. Adeyemi EO, Bastaki SMA, Chandranath SI, Hasan MY, Fahim M, Adem A (2005) Mechanism of action of leptin in preventing gastric ulcer. World J Gastroenterol 11(27):4154-4160
25. + -ATPase. J Physiol (Paris) 94:19-23
26. Francis SH, Corbin JD (1994) Structure and function of cyclic nucleotide-dependent protein kinases. Annu Rev Physiol 56:237-272
27. Neer EJ, Clapham DE (1998) Roles of G protein subunits in transmembrane signaling. Nature 333:129-134
28. Chew CS (1983) Inhibitory action of somatostatin on isolated gastric glands and parietal cells. Am J Physiol 245:G221-G229
29. Bastaki SMA, Wallace JL (1999) Pathogenesis of nonsteroidal anti-inflammatory drug gastropathy: Clues to preventive therapy. Can J Gastroenterol 13:123-127
30. Wallace JL (2001) Pathogenesis of NSAID-induced gastroduodenal mucosal injury. Best Pract Res Clin Gastroenterol 15:691-703
31. Vane JR, Botting RM (1998) Mechanism of action of anti-inflammatory drugs. Int J Tissue React 20:3-15
32. Schoen R, Vender R (1989) Mechanism of nonsteroidal anti-inflammatory drug-induced gastric damage. Am J Med 86:449-458
33. Jacobson ED, Chaudhury TK, Thompson WL (1976) Mechanism of gastric mucosal cytoprotection by prostaglandins. Gastroenterology 70:897-902
34. Choudhury TK, Jacobson ED (1978) Prostaglandin cytoprotection of gastric mucosa. Gastroenterology 74:59-63
35. Blandizzi C, Fornai M, Colucci R, Natale G, Lubrano V, Vassale C, Antonioli L, Lazzeri G, Tacca MD (2005) Lansoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage. World J Gastroenterol 11 (26):4052-4060
36. Kasuya Y, Urushidani T, Okabe S (1979) Effects of various drugs and vagotomy on indomethacin-induced gastric ulcers in the rat. Jap J Pharmacol 29: 670-673
37. Ueki S, Takeuchi K, Okabe S (1988) Gastric motility is an important factor in the pathogenesis of indomethacin-induced gastric mucosal lesions in rats. Dig Dis Sci 33 (2):209-216
38. Lacy ER, Ito S (1982) Microscopic analysis of ethanol damage to rat gastric mucosa after treatment with a prostaglandin. Gastroenterology 83:619-625
39. Szabo S, Trier J, Brown A (1985) Early vascular injury and increased vascular permeability in gastric mucosal injury caused by ethanol in the rat. Gastroenterology 88:228-236
40. Whittle BJR (1983) Potentiation of taurocholate-induced rat gastric erosions following parenteral administration of cyclooxygenase inhibitors. Br J Pharmacol 80:545-551
41. Pique JM, Whittle BJR, Esplugues JV (1989) The vasodilator role of endogenous nitric oxide in the rat gastric microcirculation. Eur J Pharmacol 174:293-296
42. Wallace JL, Tigley AW (1995) New insights into prostaglandins and mucosal defense. Aliment Pharmacol Ther 9:227-23
43. Burget DW, Stephen G, Chiverton SG, Weinhold PA, Boland CR (1990) Is there an optimal degree of acid suppression for healing of duodenal ulcer? A model of the relationship between ulcer healing and acid suppression. Gastroenterology 99:345-351
44. 2-induced secretion of surfactant phospholipids by isolated gastric mucous cells. Gastroenterology 100:1232-1240
45. 2 in cholinergic-mediated glycoprotein synthesis in canine antrum. Dig Dis Sci 37:1045-1050
46. Hatlebakk JG (2003) Review article: Gastric acidity-comparison of esomeprazole with other proton pump inhibitors. Aliment Pharmacol Ther 17(Suppl. 1):10-15